OncoAlert

NEW | OncoAlert HORIZONS🌅: Breast Cancer
PI3K pathway in HR+/HER2– breast cancer: testing, treatment and the next wave 🧬

@BarbaraPistill2 (@GustaveRoussy ) and @CristinaSaura3 (@VHIO ) cover:

🔹 Unequal access to PI3K pathway drugs across Europe
🔹 When to test for PIK3CA: up front or after CDK4/6 inhibitors?
🔹 ESR1 + PIK3CA co-mutation: SERD or PI3K inhibitor first?
🔹 Next-generation inhibitors with less hyperglycemia
🔹 Oral vs. weekly IV treatment and patient preference

HORIZONS FACULTY: @LoiSher, @JavierCortesMD, @BarbaraPistill2, @BianchiniGP, @ElisaAgostinett, Sybille Loibl, Rupert Barsch, François-Clément Bidard, Cristina Saura.

Pinging our Breast Cancer faculty
@matteolambe, @aftimosp, @E_de_Azambuja, @DrSGraff, @ErikaHamilton9, @double_whammied, @maryam_lustberg, @raalbany, @hoperugo, @stolaney1, @LoiSher, @SirohiBhawna, @jamecancerdoc, @JavierCortesMD, @JaniceTNBCmets, @Prof_Nadia_H, @nataliagandur, @FernandoOnco, @to_be_elizabeth, @Lucarecco, @GaiaGriguolo, @JankovicK, @MarioBalsaMD, @Dr_Oncologista.

Made possible thanks to an unrestricted educational grant by Roche

Why Lifestyle Changes Matter after A Prostate Cancer Diagnosis

A fascinating discussion captured during the LIVE from Lugano 🇨🇭 series at @APCCC_Lugano #APCCC26 , in collaboration with @OncoAlert 🚨

🎥 Watch here: youtu.be/6gQEj49lT8w

📢 Join us at the 44th Annual Chemotherapy Foundation Symposium (CFS®): Innovative Cancer Therapy for Tomorrow** THIS WEEK!!! In Person + Online
🎟️ FREE REGISTRATION with code: ONCOALERT
👉 buff.ly/b5A7hsf

📅 November 11–13, 2026
📍 New York, NY 🇺🇸
💻 Hybrid Meeting — In Person + Online

For more than four decades, CFS® has brought together oncology professionals from around the world to explore the latest advances in cancer care.

This 3-day meeting will feature internationally renowned experts discussing practice-changing developments across **solid tumors and hematologic malignancies**, including:

🔹 Targeted therapies & immunotherapies\
🔹 Novel biomarkers and biomarker-driven treatment approaches\
🔹 Results from pivotal clinical trials\
🔹 Personalized treatment strategies based on evolving evidence\
🔹 Management of adverse events associated with novel therapies\
🔹 Emerging combination treatment strategies

🎓 Program Co-Chairs:
• Benjamin Levy, MD\
• John Mascarenhas, MD\
• Tiffany Traina, MD, FASCO

Don't miss this opportunity to connect with leaders in oncology, stay up to date on the latest evidence, and explore what’s next in cancer care.

@KCArbourMD @mishabeltran @KellyLBolton @HosseinBorghaei @AjaiChari @End\_myeloma @DrPinkalDesai @FordePatrick @MattGalsky @YJanjigianMD @DrHKantarjian @montypal @szusmani @HelenaYu923 @gotoPER

Renowned oncologists joined COR2ED live in Madrid at #ESMO26 👉 cor2ed.com/esmo-2026/

Watch as they share their expert insights on how new data could impact clinical practice. Watch their video updates on gastric/GEJ, colorectal, and pancreatic cancer, as well as HCC, non-small cell lung cancer (including HER2-directed NSCLC), breast, prostate, and bladder cancer.

@LizzySmyth1
@YJanjigianMD
@tnewsomdavis
@LorenzaRimassa
@hongjaechon
@jhaveri_komal
@DrIacovelli

Explore timely, on-the-ground coverage of key trials presented at #ESMO26 with VJ Oncology 👉 bit.ly/4jpTaTQ

Insights from leading oncology experts, recorded live at the congress by our collaborators at VJ Oncology. Visit the @VJOncology website to watch the latest coverage!

@MiriamMerad, @GynCancerMD, @josepereag, @niazi_Dr7, @C_Ricordel, @WainbergZev, @KalinskyKevin, @sara_lonardi1, @KoheiShitara, @ProfGLongMIA, @david_tougeron, @FilippoPietran4, @VanitaNoronha, @decroisette, @abhenilmittal, @changhoon_yoo, @DrSapnaPatel, @tompowles1, @AndreaNecchi, @lab_kok, @AriRosenbergMD, @DrNeilGross, @LorenzaRimassa, @_callimaco, @RandySweisMD, @kyosuke_seguchi